UnitedHealth's stock is trading lower as the company's CEO highlighted an increase in non-urgent surgeries, which raises concerns about higher costs for insurers. This is expected to increase the company's Q2 costs and cause premiums to lag spending on claims. As a result, UnitedHealth expects its medical loss ratio for 2023 to be at the upper end of its prior outlook, which could negatively impact the stock price in the short term.